医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2013年
20期
75-76
,共2页
缪建春%杨泰源%蔡威黔%孙大勇
繆建春%楊泰源%蔡威黔%孫大勇
무건춘%양태원%채위검%손대용
丹参酮%阿托伐他汀%肾衰竭%慢性
丹參酮%阿託伐他汀%腎衰竭%慢性
단삼동%아탁벌타정%신쇠갈%만성
Tanshinone%Atorvastatin%Renal failure%Chronic
目的探讨丹参酮联合阿托伐他汀治疗慢性肾衰竭的临床疗效。方法慢性肾衰竭患者100例按照治疗方法不同分为治疗组和对照组,对照组采用常规西药治疗,治疗组在对照组的基础上采用丹参酮联合阿托伐他汀治疗,丹参多酚酸盐200mg+0.9%氯化钠注射液250 mL,静脉滴注,qd。睡前口服阿托伐他汀20mg,qd。比较两组患者治疗前后症状积分、肾功能指标、24h尿蛋白及血管内皮功能的变化。结果治疗组治疗后症状积分、24h尿蛋白定量显著低于对照组(P<0.05)。治疗组的肾功能指标尿素氮、肌酐、内生肌酐清除率的改善显著优于对照组(P<0.05)。治疗组血浆内皮素1、一氧化氮的改善显著优于对照组(P<0.05)。结论丹参酮联合阿托伐他汀能够显著改善慢性肾衰竭患者的肾功能,缓解临床症状。
目的探討丹參酮聯閤阿託伐他汀治療慢性腎衰竭的臨床療效。方法慢性腎衰竭患者100例按照治療方法不同分為治療組和對照組,對照組採用常規西藥治療,治療組在對照組的基礎上採用丹參酮聯閤阿託伐他汀治療,丹參多酚痠鹽200mg+0.9%氯化鈉註射液250 mL,靜脈滴註,qd。睡前口服阿託伐他汀20mg,qd。比較兩組患者治療前後癥狀積分、腎功能指標、24h尿蛋白及血管內皮功能的變化。結果治療組治療後癥狀積分、24h尿蛋白定量顯著低于對照組(P<0.05)。治療組的腎功能指標尿素氮、肌酐、內生肌酐清除率的改善顯著優于對照組(P<0.05)。治療組血漿內皮素1、一氧化氮的改善顯著優于對照組(P<0.05)。結論丹參酮聯閤阿託伐他汀能夠顯著改善慢性腎衰竭患者的腎功能,緩解臨床癥狀。
목적탐토단삼동연합아탁벌타정치료만성신쇠갈적림상료효。방법만성신쇠갈환자100례안조치료방법불동분위치료조화대조조,대조조채용상규서약치료,치료조재대조조적기출상채용단삼동연합아탁벌타정치료,단삼다분산염200mg+0.9%록화납주사액250 mL,정맥적주,qd。수전구복아탁벌타정20mg,qd。비교량조환자치료전후증상적분、신공능지표、24h뇨단백급혈관내피공능적변화。결과치료조치료후증상적분、24h뇨단백정량현저저우대조조(P<0.05)。치료조적신공능지표뇨소담、기항、내생기항청제솔적개선현저우우대조조(P<0.05)。치료조혈장내피소1、일양화담적개선현저우우대조조(P<0.05)。결론단삼동연합아탁벌타정능구현저개선만성신쇠갈환자적신공능,완해림상증상。
Objective To investigate the clinical ef icacy of tanshinone in joint with atorvastatin for treating chronicrenal failure. Methods One hundred patients with chronic renal failure were divided into treatment group and control group. The controls were treated with conventional medication, while the treatment group were given tanshinone and atorvastatin besides the conventional therapy. The total of 250 mL tanshinone 200mg with 0. 9% normal saline was i. d. injected, qd, and 20 mg atorvastatin was oral y administered before sleep, qd. We compared symptoms, renal function, urine protein for 24h and vascular endothelial function between two groups before and after treatment. Results The treatment group improved symptoms, lowered urine protein for 24h significantly compared to the controls ( P<0. 05). And it obviously ameliorated urea nitrogen (Bun), serum creatinine (Scr), endogenous creatinine clearance rate (Ccr) as wel as endothelin 1 ( ET1) and nitric oxide (NO)compared with the controls (P<0. 05). Conclusion The tanshinone synergism with atorvastatin significantly improved the renal function of patients with chronic renal failure and relieve the clinical symptoms.